Back to table of contents Previous article Next article Images in NeuroscienceFull AccessHippocampus, VI: Depression and the HippocampusAlexander Neumeister, M.D., , Dennis S. Charney, M.D., , and Wayne C. Drevets, M.D., Alexander NeumeisterSearch for more papers by this author, M.D., West Haven, Ct., Dennis S. CharneySearch for more papers by this author, M.D., New York, N.Y., and Wayne C. DrevetsSearch for more papers by this author, M.D., Bethesda, Md.Published Online:1 Jun 2005https://doi.org/10.1176/appi.ajp.162.6.1057AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail Recent evidence suggests that the hippocampus may be disordered in patients with major depressive disorder, with the speculation that disease-associated elevated cortisol levels might mediate alterations in hippocampal physiology and, consequently, alter cognitive performance in persons with the illness. In support of this are reports from several laboratories that have shown a reduction in hippocampal volume in the illness that is most severe in those with early age at onset, many previous episodes, longer durations of untreated illness, and a childhood abuse history. It appears that the posterior segment of the hippocampus is most consistently involved in the volume reduction in patients with major depressive disorder. Cognitive studies show that learning and memory are altered in major depressive disorder, consistent with an abnormality in the posterior hippocampus. Cellular changes in the posterior hippocampus in patients with major depressive disorder have still to be elucidated, but there is evidence of an involvement of an alteration in the serotonin and neurotropin systems. Of interest is that a reduction of mRNA for the serotonin 5-HT1a receptor has been demonstrated in patients with major depressive disorder. It is not clear whether this represents a primary abnormality specific to depression or, alternatively, whether reduced 5-HT1a receptor expression results from abnormal interaction between neurotropins (such as brain-derived neurotrophic factor) and serotonin receptors. Illustrated here is an approach to analyzing volume in the human hippocampus. Using anatomically specific criteria, hippocampal regions of interest were defined on anterior to posterior structural MRI scans (Figure, left). We averaged the volumes for these hippocampal regions of interest across all medication-free depressed patients and contrasted these with matched normal comparison subjects. Consistent with previous data from medicated patients, hippocampal volumes were reduced in persons with major depressive disorder, and these reductions were restricted to the posterior regions (Figure, right). We speculate that this volume reduction represents cellular alterations in 5-HT1a and neurotropin mechanisms, possibly related to elevated cortisol levels.One might consider that these kinds of changes underlie the alterations in learning and memory associated with major depressive disorder.Address reprint requests to Dr. Tamminga, UT Southwestern Medical Center, Department of Psychiatry, 5323 Harry Hines Blvd., #NC5.914, Dallas, TX 75390-9070; [email protected] (e-mail). Figure. The four magnetic resonance images of the medial temporal cortex show the most anterior (a) to posterior (d) regions of interest, respectively, of the hippocampus. The graph shows the average total, posterior, and anterior hippocampal volumes for depressed versus normal subjects and shows the posterior volume reduction in those with major depressive disorder. FiguresReferencesCited byDetailsCited byReduced Sulcal Depth in Central Sulcus of Major Depressive DisorderExperimental Neurobiology, Vol. 31, No. 5Sex-specific hippocampus volume changes in obstructive sleep apneaNeuroImage: Clinical, Vol. 20BMC Psychiatry, Vol. 18, No. 1Investigative Magnetic Resonance Imaging, Vol. 19, No. 1, Vol. 209PLoS ONE, Vol. 7, No. 5Neurosurgery Clinics of North America, Vol. 22, No. 2Research in Developmental Disabilities, Vol. 32, No. 5Indo-Pacific Journal of Phenomenology, Vol. 10, No. 2Emotion Modelling Towards Affective Pathogenesis1 December 2009 | Australasian Psychiatry, Vol. 17, No. 6Beyond Neurobiological Reductionism14 August 2009 | Theory & Psychology, Vol. 19, No. 4Peripheral biomarker composite associated with smaller hippocampal volumeNeuroReport, Vol. 19, No. 13Functional Magnetic Resonance in PsychiatryTopics in Magnetic Resonance Imaging, Vol. 19, No. 2The role of hippocampus in the pathophysiology of bipolar disorderBehavioural Pharmacology, Vol. 18, No. 5-6Neuroimaging Clinics of North America, Vol. 17, No. 4Current Opinion in Psychiatry, Vol. 20, No. 1 Volume 162Issue 6 June 2005Pages 1057-1057 Metrics PDF download History Published online 1 June 2005 Published in print 1 June 2005